385 related articles for article (PubMed ID: 10714630)
1. Fas and Fas-ligand expression in human pancreatic cancer.
Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
[TBL] [Abstract][Full Text] [Related]
2. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
4. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of non-apoptosis by Fas stimulation alone versus apoptosis with an additional actinomycin D in cultured cardiomyocytes.
Aoyama T; Takemura G; Maruyama R; Kosai K; Takahashi T; Koda M; Hayakawa K; Kawase Y; Minatoguchi S; Fujiwara H
Cardiovasc Res; 2002 Sep; 55(4):787-98. PubMed ID: 12176128
[TBL] [Abstract][Full Text] [Related]
7. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand expression in cystic fibrosis airway epithelium.
Durieu I; Amsellem C; Paulin C; Chambe MT; Bienvenu J; Bellon G; Pacheco Y
Thorax; 1999 Dec; 54(12):1093-8. PubMed ID: 10567629
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
[TBL] [Abstract][Full Text] [Related]
10. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand expression in pancreatic adenocarcinoma.
Pernick NL; Sarkar FH; Tabaczka P; Kotcher G; Frank J; Adsay NV
Pancreas; 2002 Oct; 25(3):e36-41. PubMed ID: 12370548
[TBL] [Abstract][Full Text] [Related]
12. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of FAS and FAS-ligand in chronic pancreatitis: correlation with apoptosis.
Kornmann M; Ishiwata T; Maruyama H; Beger HG; Korc M
Pancreas; 2000 Mar; 20(2):123-8. PubMed ID: 10707926
[TBL] [Abstract][Full Text] [Related]
14. p38 mitogen-activated protein kinase is involved in Fas ligand expression.
Hsu SC; Gavrilin MA; Tsai MH; Han J; Lai MZ
J Biol Chem; 1999 Sep; 274(36):25769-76. PubMed ID: 10464315
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
Sata M; Suhara T; Walsh K
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
[TBL] [Abstract][Full Text] [Related]
16. Fas, ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line.
Caricchio R; D'Adamio L; Cohen PL
Cell Death Differ; 2002 May; 9(5):574-80. PubMed ID: 11973615
[TBL] [Abstract][Full Text] [Related]
17. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.
Ortiz-Arduan A; Danoff TM; Kalluri R; González-Cuadrado S; Karp SL; Elkon K; Egido J; Neilson EG
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1193-201. PubMed ID: 8997393
[TBL] [Abstract][Full Text] [Related]
19. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
20. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]